-
Trichostatin A: Reading HDAC Biology Beyond Histones
2026-09-09
Trichostatin A (TSA) is more than a tool for inducing histone hyperacetylation. This article connects TSA assay design with emerging evidence on HDAC6-regulated tubulin lactylation, showing how orthogonal readouts can sharpen cancer and differentiation research.
-
Tubastatin A: Interpreting HDAC6-Linked Injury
2026-09-09
Tubastatin A is a selective HDAC6 inhibitor whose value extends beyond target potency. This article explains how to connect HDAC6 engagement with microtubule, inflammatory, and programmed-cell-death readouts while translating porcine cardiac-arrest evidence into better experimental decisions.
-
SmD2 Acetylation Links Splicing to PARP Response in HCC
2026-09-08
The reference study identifies SmD2 acetylation as a regulatory connection between core spliceosome activity, BRCA1/FANC cassette-exon selection, DNA-damage repair, and PARP-inhibitor sensitivity in hepatocellular carcinoma. Its findings support a combination strategy in which HDAC inhibition is used to alter SmD2 stability and improve responses to PARP inhibition, although validation in additional tumor contexts remains necessary.
-
How Early Pheromones Accelerate Neurodegeneration
2026-09-08
Peng et al. show that exposure to the C. elegans pheromones ascr#3 and ascr#10 during the L1 stage remodels neural development and increases neurodegeneration in adulthood. The study defines a circuit linking ASK and ASI chemosensory neurons to AIA interneurons, insulin-like signaling, and neuronal autophagy, providing a mechanistic framework for how early environmental cues can influence later proteostasis.
-
EZ Cap™ OVA mRNA for Immune Research
2026-09-07
EZ Cap™ OVA mRNA provides a standardized ovalbumin antigen source for immune response immunogen studies, airway hyperreactivity models, gene expression studies, and vaccine development research. Its Cap 1 structure, poly(A) tail, and defined handling workflow also make it a practical tool for comparing mRNA delivery systems while monitoring expression and inflammatory effects.
-
PP 3: A Better Control for Src Signaling Translation
2026-09-07
Translational studies often overinterpret inhibitor-sensitive phenotypes when scaffold, vehicle, and pathway effects are not separated. This thought-leadership article explains how PP 3, a research use only chemical and negative control for PP 2, can strengthen Src kinase signaling pathway research while connecting vascular ROS biology to more rigorous experimental design.
-
Ions Improve CPP-Mediated Nucleic Acid Delivery
2026-09-05
The reference study shows that supplementing cell-penetrating peptide and nucleic acid nanoparticles with selected inorganic ions can improve productive delivery by reshaping particle properties and promoting endosomal escape. Its main practical contribution is to position ion composition as a controllable formulation variable rather than treating the transfection medium as a passive environment.
-
Exosomal Egr2 Protects Neurons After Ischemic Stroke
2026-09-04
This 2025 study links bone marrow mesenchymal stem cell-derived exosomal Egr2 to neuronal protection after oxygen-glucose deprivation/reoxygenation through an RNF8/DAPK1 regulatory axis. Its combination of exosome characterization, promoter validation, co-immunoprecipitation, and rescue experiments provides a mechanistic framework for studying paracrine neuroprotection, while the in vitro design leaves important questions about in vivo translation.
-
SP2509 for Reproducible LSD1 Assays
2026-09-04
SP2509 (SKU B4894) is a Lysine-specific demethylase 1 antagonist for mechanism-led viability, apoptosis, and differentiation studies, particularly in acute myeloid leukemia models. This practical guide explains how to control solubility, interpret assay readouts, and select a reliable research-grade workflow without confusing biochemical potency with cellular response.
-
Canagliflozin Workflows for Renal Mitochondria
2026-09-03
Canagliflozin enables more than glucose-lowering studies: it supports coordinated analysis of renal glucose handling, proximal-tubule mitochondrial structure, and bioenergetics. This practical guide translates recent hypertensive–diabetic mouse findings into reproducible in vitro and in vivo workflow choices, controls, and troubleshooting steps.
-
EZ Cap™ Cas9 mRNA (m1Ψ) Workflow Guide
2026-09-03
Build a time-controlled CRISPR-Cas9 genome editing workflow around a capped, modified Cas9 transcript rather than constitutive DNA expression. This guide connects practical dosing, RNA handling, mammalian-cell assay design, and the reference study’s nuclear-export findings to help improve reproducibility and specificity.
-
Rocilinostat (ACY-1215): HDAC6 Research Guide
2026-09-02
Rocilinostat, also called ACY-1215, is a selective HDAC6 inhibitor with a reported biochemical IC50 of 5 nM. Preclinical multiple myeloma studies link HDAC6 inhibition with increased α-tubulin acetylation, reduced tumor-cell viability, apoptosis, and enhanced proteasome-inhibitor activity.
-
miR-4769-3p and Adipogenesis in Systemic Sclerosis
2026-09-02
Tang et al. identify miR-4769-3p as an inhibitor of subcutaneous adipose tissue recovery in systemic sclerosis and define a mechanistic USP18/VDAC2 axis connecting microRNA activity with adipogenesis. The study combines patient samples, a bleomycin-induced mouse model, and 3T3-L1 cell experiments to support a potential molecular target for studying adipose loss and skin fibrosis.
-
Apicidin Disrupts Oocyte Maturation and Histone Acetylation
2026-09-01
A 2026 study identifies a reproductive-toxicity mechanism for Apicidin by linking impaired oocyte meiotic maturation with spindle defects, actin disorganization, altered histone and tubulin acetylation, DNA damage, and early apoptosis. The work provides a framework for evaluating Apicidin exposure in germ-cell models while highlighting that HDAC-related molecular changes should not be interpreted as proof of direct target inhibition without biochemical validation.
-
Fucoidan: Gut–Liver Axis Research Workflows
2026-09-01
Fucoidan connects cancer-cell apoptosis assays with gut–liver barrier and inflammatory models, enabling researchers to separate direct tumor effects from host-mediated protection. This practical guide covers formulation, NETs-focused readouts, assay controls, and troubleshooting for more reproducible translational studies.